Qianhua Cao

Key Laboratory Of Respiratory Disease Of Ningbo
Ningbo, 315010, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Targeted Delivery of Bilirubin to Pulmonary Endothelium Mitigates Paraquat-Induced Lung Injury.

Targeted Delivery of Bilirubin to Pulmonary Endothelium Mitigates Paraquat-Induced Lung Injury.

Journal: International journal of nanomedicine

Published: April 23, 2026

Discovery and Validation of Lung Cancer Biomarkers Based on Proteomic Analysis of Bronchoalveolar Lavage Fluid from the Self-Controlled Pulmonary Lobes.

Discovery and Validation of Lung Cancer Biomarkers Based on Proteomic Analysis of Bronchoalveolar Lavage Fluid from the Self-Controlled Pulmonary Lobes.

Journal: Journal of proteome research

Published: April 01, 2026

Lactylation of Mutation-Prone RAS Residues Mimics Oncogenic Mutations and Drives Constitutive Activation.

Lactylation of Mutation-Prone RAS Residues Mimics Oncogenic Mutations and Drives Constitutive Activation.

Journal: Cancer communications (London, England)

Published: January 04, 2026

ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression.

ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression.

Journal: Cell discovery

Published: July 24, 2025

RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization.

RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization.

Journal: Molecular cancer

Published: June 02, 2025

CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer.

CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer.

Journal: Cell death and differentiation

Published: April 25, 2025

Acetylation suppresses breast cancer progression by sustaining CLYBL stability.

Acetylation suppresses breast cancer progression by sustaining CLYBL stability.

Journal: Journal of translational medicine

Published: November 06, 2024

AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.

AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.

Journal: Breast cancer research : BCR

Published: November 23, 2023

IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.

IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.

Journal: Cancer letters

Published: August 29, 2023

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 18, 2022

HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.

HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.

Journal: Frontiers in oncology

Published: September 20, 2021

Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.

Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.

Journal: Theranostics

Published: December 17, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026